[1] Cui J, Gong R, Hu S, et al. Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway[J]. Life Sci, 2018, 192:293-303. [2] Hu Y, Xu Q, Li H, et al. Dapagliflozin reduces apoptosis of diabetic retina and human retinal microvascular endothelial cells through ERK1/2/cPLA2/AA/ROS pathway independent of hypoglycemic[J]. Front Pharmacol, 2022, 13:827896-827910. [3] Luo C, Hou C, Yang D, et al. Urolithin C alleviates pancreatic β-cell dysfunction in type 1 diabetes by activating Nrf2 signaling[J]. Nutr Diabetes, 2023, 13:24-35. [4] Fu J, Aung MH, Prunty MC, et al. Tauroursodeoxycholic acid protects retinal and visual function in a mouse model of type 1 diabetes[J]. Pharmaceutics, 2021, 13:1154-1167. [5] 韩莎莎, 尹丹, 李跃峰, 等. 连翘苷通过调控CTRP3表达对高糖诱导的人视网膜血管内皮细胞损伤的影响及其机制研究[J]. 眼科新进展, 2024, 44:354-359. [6] 张含林, 林辉, 郭航远. 牛磺熊去氧胆酸通过调节内质网应激抑制转化生长因子β1所诱导的心肌成纤维细胞纤维化[J]. 中国心血管杂志, 2024, 29:56-64. [7] 姜冰, 冯茂耕, 郑艮子, 等. KEAP1-NRF2/HO-1通路介导LED红光促高糖诱导下人牙周膜干细胞成骨分化及减轻氧化损伤[J]. 口腔疾病防治, 2023, 31:389-399. [8] Lai QL, Xie T, Zheng WD, et al. Regulation role of miR-204 on SIRT1/VEGF in metabolic memory induced by high glucose in human retinal pigment epithelial cells[J]. Int J Ophthalmol, 2024, 17:1232-1237. [9] Liu Z, Li Y, Bao J, et al. Astaxanthin ameliorates benzalkonium chloride-induced dry eye disease through suppressing inflammation and oxidative stress via Keap1-Nrf2/HO-1 signaling pathways[J]. Animal Model Exp Med, 2025, 8(6):1056-1079. [10] Yang T, Lin X, Li H, et al. Acetyl-11-Keto-Beta boswellic acid (AKBA) protects lens epithelial cells against H2O2-induced oxidative injury and attenuates cataract progression by activating Keap1/Nrf2/HO-1 signaling[J]. Front Pharmacol, 2022, 13:927871-927884. [11] Feng J, Ji K, Pan Y, et al. Resveratrol ameliorates retinal ischemia-reperfusion injury by modulating the NLRP3 inflammasome and Keap1/Nrf2/HO-1 signaling pathway[J]. Mol Neurobiol, 2024, 61:8454-8466. [12] Giurdanella G, Longo A, Distefano A, et al. The anti-inflammatory effect of the β1-adrenergic receptor antagonist metoprolol on high glucose treated human microvascular retinal endothelial cells[J]. Cells, 2021, 11:51-72. [13] Wang Q, Li W, Zhang X, et al. Tauroursodeoxycholic acid protects Schwann cells from high glucose-induced cytotoxicity by targeting NLRP3 to regulate cell migration and pyroptosis[J]. Biotechnol Appl Biochem, 2024, 71:28-37. [14] Mohamed NA, Ithmil MT, Elkady AI, et al. Tauroursodeoxycholic acid (TUDCA) relieves streptozotocin (STZ)-induced diabetic rat model via modulation of lipotoxicity, oxidative stress, inflammation, and apoptosiset al[J]. Int J Mol Sci, 2024, 25:6922-6969. [15] Lenin R, Jha KA, Gentry J, et al. Tauroursodeoxycholic acid alleviates endoplasmic reticulum stress-mediated visual deficits in diabetic tie2-TNF transgenic mice via TGR5 signaling[J]. J Ocul Pharmacol Ther, 2023, 39:159-174. |